Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jul 2, 2010
A class of drugs that prevent clot breakdown and reduce internal bleeding could save lives after trauma, according to an editorial in the June 15, 2010 issue of The Lancet. This video is an interview with Jerrold H. Levy, MD, FAHA, author of the editorial. The editorial accompanies a report on a randomized clinical trial evaluating the use of the antifibrinolytic agent tranexamic acid in more than 20,000 trauma patients from 42 countries. Levy is professor of anesthesiology at Emory University School of Medicine and co-director of cardiothoracic anesthesiology.